Malaria Is Spreading to Areas Once Considered Low-Risk: What Travelers Need to Know in 2026

In June 2026, the CDC posted travel notices for rising malaria in both Yemen and Mayotte, and the Yemen notice specifically flagged increased cases in areas that were previously considered low-risk. That detail matters more than the destinations themselves. Malaria is not staying inside the lines on old risk maps, and the single most reliable protection, a prescription antimalarial taken correctly, still prevents the large majority of cases. Worldwide there were an estimated 263 million malaria cases and 597,000 deaths in 2023, according to the World Health Organization. Our physician-founded clinical team builds malaria prevention plans for travelers every week, and the pattern we see is simple: the travelers who get sick are almost always the ones who skipped or stopped their pills, not the ones who took them.

What the June 2026 CDC Notices Actually Said

The CDC issued two malaria-related travel notices in early June 2026. The first, for Mayotte, a French island territory in the Indian Ocean, was posted on June 2 and reported increased malaria cases alongside an ongoing chikungunya outbreak. The second, for Yemen, was posted on June 11 and reported increased malaria cases including in areas that had previously been classified as low-risk.

The phrase "previously considered low-risk" is the part travelers should read twice. Malaria risk is not fixed. It shifts with rainfall, mosquito populations, conflict, the breakdown of health and spraying programs, and the movement of people. An area that was a low priority on last year's map can become a real exposure this year. That is exactly why we treat current notices, not memory or old advice, as the starting point for every plan.

This is not only a faraway problem. A 2026 CDC operational guidance report in the MMWR addressed locally acquired, mosquito-transmitted malaria within the United States, which had reappeared after two decades without local transmission. The same competent mosquitoes that spread malaria abroad exist in parts of the US, which is part of why the disease deserves respect rather than complacency.

Why Malaria Maps Keep Changing

Malaria is caused by Plasmodium parasites, spread to people through the bite of infected female Anopheles mosquitoes. Five parasite species infect humans, and Plasmodium falciparum, the most dangerous, is responsible for most severe disease and nearly all deaths. The geography of the disease tracks the geography of the mosquito, and that geography moves.

The global burden remains heavily concentrated. The WHO World Malaria Report 2024 found that 94 percent of all cases in 2023 occurred in the African Region, and about 95 percent of deaths. More than half the global burden sat in just five countries: Nigeria, the Democratic Republic of the Congo, Uganda, Ethiopia, and Mozambique. But concentration at the top does not mean the edges are safe. Cases rose by roughly 11 million between 2022 and 2023, and progress that had been steady since 2000 has leveled off over the past decade.

For a traveler, the practical takeaway is that risk is dynamic. Climbing case counts in places like Yemen and Mayotte, and the note that exposure is reaching previously low-risk zones, are the kind of signal that should prompt a fresh look at your prevention plan rather than a shrug.

Who Actually Needs Malaria Prophylaxis

Not every trip requires antimalarial pills, and we do not believe in prescribing them for travel that carries no real exposure. The decision comes down to your specific itinerary, the regions and elevations you will visit, the season, the length of stay, and your own medical history.

You most likely need prophylaxis if your trip includes time in malaria-endemic regions of sub-Saharan Africa, parts of South Asia and Southeast Asia, the Amazon basin and other parts of South America, or other areas with active transmission. Rural and lower-elevation areas generally carry more risk than major cities and high-altitude zones, but there are many exceptions, which is why itinerary detail matters so much.

The risk of severe malaria is higher in certain groups, including pregnant travelers, young children, older adults, and people without a functioning spleen or with weakened immune systems. Those travelers need extra care in planning, and sometimes a different medication choice. When you start a visit with Wandr, our clinicians review exactly where you are going and who you are before recommending anything.

Malarone: The Antimalarial We Prescribe Most

For most travelers who need malaria prevention, Wandr prescribes atovaquone-proguanil, known by the brand name Malarone. It is a daily tablet that the CDC lists as a first-line option for most malaria-endemic destinations, and our providers can prescribe it as part of your pre-trip plan.

The dosing schedule is one of the reasons we like it for shorter trips. You start atovaquone-proguanil one to two days before entering the malaria area, take it once daily during your stay, and continue for seven days after you leave. That seven-day tail is short compared with some older drugs, which makes it easier to finish the full course, and finishing the full course is the entire point.

Atovaquone-proguanil is generally well tolerated. The most common side effects are mild stomach upset and headache, and taking it with food or a milky drink helps. It is not the right choice for everyone, including people with significant kidney impairment, so the medication decision should always follow a clinical review rather than a guess. Other antimalarials exist, including doxycycline and mefloquine, and the CDC recognizes them for specific situations and destinations. We walk through how these options compare in our guides on Malarone versus doxycycline and Malarone versus mefloquine so you can understand the tradeoffs before your visit.

Plan ahead, not at the airport. Antimalarials need to be started before you enter a malaria area, so the time to sort this out is during trip planning, not the week of departure. Start your pre-trip visit on Wandr and our providers can review your itinerary and, when appropriate, send a prescription to your local pharmacy for pickup.

Pills Are Not the Whole Plan: Bite Prevention Still Matters

No antimalarial is 100 percent effective, so every malaria prevention plan has a second layer: avoiding mosquito bites in the first place. Anopheles mosquitoes that carry malaria typically bite between dusk and dawn, which shapes the advice.

Use an EPA-registered insect repellent with DEET, picaridin, or oil of lemon eucalyptus on exposed skin, and reapply as directed. Wear long sleeves and long pants in the evening, especially in rural areas. Sleep under an insecticide-treated bed net if your room is not well screened or air-conditioned, and treat clothing and gear with permethrin before you travel. None of these replaces your pills, and your pills do not replace them. The two work together.

Bite prevention also protects you against the other mosquito-borne diseases that often share the same geography, including dengue and chikungunya, which is part of why the Mayotte notice flagged both malaria and chikungunya at once.

What to Do If You Develop a Fever After Travel

Here is the rule we want every traveler to remember: any fever during or after travel to a malaria area is malaria until proven otherwise. Symptoms usually begin between one week and one month after exposure, but they can appear later, sometimes months after you return home. Early malaria looks like the flu, with fever, chills, headache, body aches, and fatigue, which is exactly why it gets missed.

Falciparum malaria can progress from mild to life-threatening within hours, so this is not a wait-and-see situation. If you develop a fever after traveling to a malaria-endemic region, seek medical evaluation and testing urgently, and tell the clinician where you traveled and when. Prompt diagnosis and treatment are highly effective. Delay is what turns malaria dangerous.

Because many malaria destinations in Africa also carry other vaccine-preventable risks, your pre-trip plan should cover more than antimalarials. Travelers heading to sub-Saharan and West Africa should also confirm their routine immunizations are current, including the diphtheria and tetanus boosters that the CDC highlighted in its 2026 diphtheria travel alert for seven African countries.

Building Your 2026 Malaria Prevention Plan with Wandr

Malaria prevention is one of the most solvable problems in travel health. The science is settled, the medications work, and the protocol is straightforward once your itinerary is matched to the right plan. The hard part for most travelers is simply doing it early enough and following through.

That is the part we handle. When you start a visit with Wandr, our clinicians review your destinations, dates, and history, tell you honestly whether you need antimalarials at all, and when you do, prescribe the right one for your trip. If you are still deciding whether your itinerary calls for pills, our guide on whether you need malaria pills is a good place to start, and our complete malaria prevention guide covers the science in depth.

The 2026 notices are a useful reminder that malaria maps are not static. Build your plan around current guidance, start your medication on time, layer in bite prevention, and treat any post-travel fever as urgent. Do those four things and you have done nearly everything within your control.

Get your malaria plan sorted before you go. Start your free pre-trip health check and let our providers match your itinerary to the right protection.

Frequently Asked Questions

Is malaria really spreading to new areas in 2026? The CDC's June 2026 notice for Yemen specifically reported increased malaria cases including in areas previously considered low-risk, and a separate notice flagged rising cases in Mayotte. Globally, the WHO estimated 263 million cases in 2023, about 11 million more than the year before, and noted that progress against malaria has stalled over the past decade. Risk maps shift with climate, mosquito populations, and local conditions, so current guidance matters more than older maps.

Which malaria pill does Wandr prescribe? For most travelers, Wandr prescribes atovaquone-proguanil, known by the brand name Malarone, a once-daily tablet the CDC lists as a first-line option for most malaria-endemic destinations. You start it one to two days before entering the malaria area and continue for seven days after leaving. Our clinicians confirm it is appropriate for you during your visit, since it is not the right choice for everyone.

When should I start taking antimalarial medication? Atovaquone-proguanil is started one to two days before you enter the malaria area, taken daily during the trip, and continued for seven days after you leave. Because it must be started before exposure, the time to arrange it is during trip planning, not the day before departure. Starting a visit with Wandr early gives you time to get the prescription and fill it before you fly.

Do I still need bug spray if I take malaria pills? Yes. No antimalarial is 100 percent effective, so bite prevention is the essential second layer. Use an EPA-registered repellent, cover up at dusk and dawn when malaria mosquitoes bite, and sleep under a treated net if your room is not screened or air-conditioned. Bite prevention also protects against dengue and chikungunya, which often share the same regions.

What should I do if I get a fever after visiting a malaria area? Treat any fever during or after travel to a malaria region as malaria until proven otherwise. Symptoms usually appear one week to one month after exposure but can come later. Falciparum malaria can become life-threatening within hours, so seek urgent medical evaluation and testing, and tell the clinician exactly where and when you traveled. Prompt treatment is highly effective.

This article is for general educational purposes and does not replace an individual clinical assessment. Wandr's licensed providers review your specific itinerary and health history before recommending or prescribing any medication. Sources: CDC Travelers' Health Notices (2026), WHO World Malaria Report 2024, and CDC MMWR operational guidance on locally acquired malaria (2026).